Global Pharma Blisters Packaging Market Overview
The Pharma Blisters Packaging Market Size was estimated at 8.69 (USD Billion) in 2022. The Pharma Blisters Packaging Industry is expected to grow from 9.09(USD Billion) in 2023 to 13.6 (USD Billion) by 2032. The Pharma Blisters Packaging Market CAGR (growth rate) is expected to be around 4.58% during the forecast period (2024 - 2032).
Key Pharma Blisters Packaging Market Trends Highlighted
Key market drivers in the Pharma Blisters Packaging Market include rising demand for convenience and patient compliance, increasing prevalence of chronic diseases, and technological advancements in packaging materials.Opportunities to be explored in the market lie in the development of eco-friendly and sustainable packaging solutions, the integration of smart packaging features, and the expansion into emerging markets. The market is also expected to witness growth due to increasing demand for personalized medicine and the adoption of blister packaging in clinical trials.Recent trends include the growing popularity of customized blister packaging, the adoption of tamper-evident packaging to ensure product integrity, and the use of advanced printing technologies to improve the aesthetics and functionality of packaging. The market is also witnessing a shift towards automation and digitalization to enhance efficiency and reduce costs.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Pharma Blisters Packaging Market Drivers
Growing Demand for Blister Packaging in the Pharmaceutical Industry
Blister packaging is an attractive form of pharmaceutical packaging due to the packaging’s ability to protect the product from moisture, oxygen, and light. Additionally, it is tamper-evident, which is important for pharmaceuticals, given the safety issues associated with medications. The demand for pharmaceuticals and, thus, blister packaging as well is expected to continue to rise. The Pharma Blisters Packaging Market Industry was reported to have a value of USD 8.7 billion in 2020 and is forecasted to reach USD 13.6 billion by 2032, growing at a CAGR of 4.58% throughout the forecast period.There are multiple factors driving the growth of the market, such as the increasing prevalence of chronic diseases, the growing geriatric population, the increasing embracement of personalized medicine, as well as the contribution of emerging economies, such as China and India. Given the industry’s critical role in the demand for blister packaging in the pharmaceutical area, it is expected that the trend will remain a significant part of the growth of the market in the coming years.
Advancements in Blister Packaging Technology
Recent years have seen the development of technology in the blister packaging industry. These advancements result in more efficient, cheaper to manufacture, and pack products than those designed years ago. The automation mentioned above helps to reduce labor costs and improve production efficiency. Modern materials are more durable and less susceptible to deformation or damage. As such, the way technology has advanced is a positive force behind the continuous growth of the Pharma Blisters Packaging Market Industry.
Increasing Focus on Sustainability
There is a trend for the increasing demand for sustainability in the packaging industry, and it is largely due to the fact that much attention is drawn to the environmental impact of packaging waste. Blister packaging, however, is a relatively sustainable type of packaging since it is recyclable and can be made of already recycled materials. It is possible to assume, that with the increasing demand for sustainability of packaging, blister packaging will become more common among pharmaceutical companies.
Pharma Blisters Packaging Market Segment Insights
Pharma Blisters Packaging Market Material Type Insights
The Material type segment of the Pharma Blisters Packaging Market is divided into Plastic, Aluminium, Paper, and Glass. Plastic is observed as the most dominant material type and will account for over 60% of the market share in 2023. The reason for the growth of this segment is due to the features of the plastic-type in the packaging of pharmaceutical products. Firstly, plastic blister is lightweight, flexible, and cost-effective. Secondly, they provide excellent barrier properties against moisture and oxygen. Moreover, plastic blisters ensure the stability and efficacy of drugs.The market of plastic blister packaging will be growing at a 4.5% CAGR during the forecast period. It is predicted that it will be valued at $ 9.09 Bn in 2023 and $ 13.6 Bn in 2032. Aluminium is the second type of material used for the packaging of pharmaceutical products. It is more suitable for drugs due to the need for a higher level of protection from light and moisture. Thus, aluminium blisters are more rigid and durable in comparison to plastic. They are also more resistant to contamination and microbial growth. However, this type of material will be less than plastic in its market share, accounting for about 20% in 2023.This is due to the higher price of the aluminum blisters. The market analysis of aluminum blisters will also be growing at a 3.8% CAGR during the forecast period. It is supposed that they will be valued at about $ 2.5 Bn in 2032. A more sustainable and cost-effective alternative to plastic and aluminum is a paper blister. It is in the third position of the material type segment. The major advantage of the type is in the biodegradability and recycleability of the product. The package is made of recycled paperboard. The analysis states that its market will be growing with a 4.2% CAGR during the forecast period.It will be valued at $ 1.2 Bn in 2032. The last type of material is glass. This type is chemically inert and resistant to breakage. The package of the material is made of borosilicate glass. They provide the best protection against moisture, oxygen, and light. This is why they are used in the packaging of high-value and sensitive drugs. However, their price is the highest in comparison to the three other types. The market analysis states that it will be growing with a 3.5% CAGR during the forecast period. It will be valued at $ 0.6 Bn in 2032.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Pharma Blisters Packaging Market Application Insights
The Pharma Blisters Packaging Market segmentation by Application provides critical information on the different types of markets included. The segment that includes pharmaceutical segment has the highest market share due to the increase in the use of blister packaging in the pharmaceutical industry. The use is because of the caregivers’ and the patients’ assurance of the safety of the products. In 2023, the pharmaceutical segment had a 60% Pharma Blisters Packaging Market revenue. The dietary supplements segment is the next contributor, with an increase in the use of supplements by different populations.Other segments, such as cosmetics and medical devices, also contribute, but their growth is not at an alarming stage. Additionally, the Pharma Blisters Packaging Market data indicates that, between 2023 and 2032, the pharmaceutical segment will continue to lead, having a growth rate of 4.8%. The growth is attributed to the increase in the use of efficient and effective products in the packaging. The dietary supplements segment follows with a CAGR of 4.2%. Both cosmetics and medical devices are expected to have an average growth of 3.8%.
Pharma Blisters Packaging Market Packaging Type Insights
The Packaging Type segment of the Pharma Blisters Packaging Market is categorized into Cold-formed blisters, Thermoformed blisters, Clamshells, and Slide blisters. Among these, Thermoformed Blisters held the largest revenue share in the market in 2023 and is projected to maintain its dominance throughout the forecast period. The growth of this segment can be attributed to the increasing demand for high-quality and cost-effective packaging solutions in the pharmaceutical industry. Cold-formed blisters are expected to witness a steady growth rate during the forecast period, owing to their low cost and ease of production.Clamshells and Slide blisters are also gaining popularity due to their durability and ability to protect the product from damage.
Pharma Blisters Packaging Market End-Use Insights
The Pharma Blisters Packaging Market is segmented by End-Use into Hospitals and clinics, Pharmacies, Retail stores, and E-commerce. Among these segments, Hospitals and clinics held the largest market share in 2023, accounting for around 45% of the Pharma Blisters Packaging Market revenue. This dominance can be attributed to the increasing number of hospitals and clinics worldwide, coupled with the rising demand for blister packaging solutions for the safe and efficient storage and dispensing of pharmaceutical products. Pharmacies are expected to be the fastest-growing segment during the forecast period, owing to the growing number of retail pharmacies and the increasing preference for over-the-counter medications.E-commerce is another rapidly growing segment, driven by the convenience and accessibility it offers to consumers.
Pharma Blisters Packaging Market Regional Insights
North America dominated the Pharma Blisters Packaging Market revenue in 2023 and is projected to maintain its dominance throughout the forecast period. The large pharmaceutical and healthcare industries in the region, along with the increasing adoption of blister packaging for pharmaceutical products, are major factors driving the growth of the market in North America. The high demand for convenience and safety in pharmaceutical packaging is also contributing to the growth of the market in this region. Europe is another major market for Pharma Blisters Packaging, with a significant share of the Pharma Blisters Packaging Market revenue.The presence of a large number of pharmaceutical companies and the increasing demand for blister packaging for pharmaceutical products are major factors driving the growth of the market in Europe. The APAC region is the fastest-growing market for Pharma Blisters Packaging, with a high growth rate expected over the forecast period. The growth of the pharmaceutical industry in the region, along with the increasing adoption of blister packaging for pharmaceutical products, is driving the growth of the market in APAC. South America and MEA are also significant markets for Pharma Blisters Packaging, with steady growth expected over the forecast period.The increasing demand for pharmaceutical products and the growing adoption of blister packaging in these regions are driving the growth of the market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Pharma Blisters Packaging Market Key Players And Competitive Insights
Leading Pharma Blisters Packaging Market players have been adopting various growth strategies to broaden their presence, diversify their product portfolios, and boost their competencies. Top Pharma Blisters Packaging Market players focus on designing new packaging solutions applicable to the specificities of the pharmaceutical industry. Technological breakthroughs and rising awareness about business and social sustainability are the key factors accelerating Pharma Blisters Packaging Market growth.The Australian company Amcor is one of the major players in the Pharma Blisters Packaging Market. The company offers an extensive portfolio of blister packaging products. Its R&D activities concentrate on the development and elaboration of novel packaging materials and technologies that would contribute to increased product safety and quality and decreased environmental impact. Amcor’s competitive advantage is linked to its vast geographical presence and strong customer base.The German-based company, Gerresheimer, is another major Pharma Blisters Packaging Market player. The organization specializes in the design and production of glass and plastic products for the healthcare industry. Gerresheimer has developed an innovative and customer-oriented strategy that has facilitated the creation of sophisticated blister packaging systems suitable for the pharmaceutical market. The appeal of Gerresheimer’s offerings is also related to its manufacturing facilities located worldwide and its large distribution network.
Key Companies in the Pharma Blisters Packaging Market Include:
-
DS Smith
-
Huhtamäki
-
WestRock
-
Sealed Air
-
RPC Group
-
Alufoil Products
-
Berry Global
-
Plastoform Industry
-
Silgan Holdings
-
Sonoco Products
-
Amcor
-
Mondi Group
-
Greif
-
Ardagh Group
Pharma Blisters Packaging Market Industry Developments
The pharma blisters packaging market is anticipated to reach USD 13.6 billion by 2032, expanding at a CAGR of 4.58% from 2024 to 2032. Rising demand for pharmaceutical products, increasing prevalence of chronic diseases, and growing adoption of blister packaging in the healthcare industry are major factors driving market growth. Technological advancements, such as the development of child-resistant and sustainable packaging solutions, are further propelling market expansion. Key industry participants are focusing on strategic collaborations and acquisitions to enhance their market position. Recent news developments include Amcor's acquisition of Sonoco's flexible packaging business and Berry Global's partnership with Silgan Dispensing to develop innovative packaging solutions for the pharmaceutical industry.
Pharma Blisters Packaging Market Segmentation Insights
Pharma Blisters Packaging Market Material Type Outlook
-
Plastic
-
Aluminum
-
Paper
-
Glass
Pharma Blisters Packaging Market Application Outlook
-
Pharmaceutical
-
Dietary supplements
-
Cosmetics
-
Medical devices
Pharma Blisters Packaging Market Packaging Type Outlook
-
Cold-formed blisters
-
Thermoformed blisters
-
Clamshells
-
Slide blisters
Pharma Blisters Packaging Market End-Use Outlook
-
Hospitals and clinics
-
Pharmacies
-
Retail stores
-
E-commerce
Pharma Blisters Packaging Market Regional Outlook
-
North America
-
Europe
-
South America
-
Asia Pacific
-
Middle East and Africa
| Report Attribute/Metric |
Details |
| Market Size 2022 |
8.69(USD Billion) |
| Market Size 2023 |
9.09(USD Billion) |
| Market Size 2032 |
13.6(USD Billion) |
| Compound Annual Growth Rate (CAGR) |
4.58% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
DS Smith, Huhtamäki, WestRock, Sealed Air, RPC Group, Alufoil Products, Berry Global, Plastoform Industry, Silgan Holdings, Sonoco Products, Amcor, Mondi Group, Greif, Ardagh Group |
| Segments Covered |
Material Type, Application, Packaging Type, End-Use, Regional |
| Key Market Opportunities |
Child-resistant Blister Packaging SolutionsBlister Packaging for BiologicsSustainability in Blister PackagingCustomization of Blister PackagingAntiCounterfeit Blister Packaging |
| Key Market Dynamics |
Growth in demand for generic drugs Increasing prevalence of chronic diseases Technological advancements in packaging Rise in demand for child-resistant packaging.Growing awareness of counterfeiting |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Pharma Blisters Packaging Market is projected to reach a value of 9.09 billion USD in 2023, exhibiting a steady growth trajectory.
The Pharma Blisters Packaging Market is anticipated to expand at a CAGR of 4.58% from 2024 to 2032, indicating a promising growth outlook.
North America is projected to dominate the Pharma Blisters Packaging Market, driven by factors such as the presence of leading pharmaceutical companies and stringent regulatory standards.
The growth of the Pharma Blisters Packaging Market is primarily attributed to the increasing demand for convenient and cost-effective packaging solutions, rising healthcare expenditure, and the growing prevalence of chronic diseases.
Some of the prominent players in the Pharma Blisters Packaging Market include Amcor, Huhtamaki, Sonoco Products Company, and West Pharmaceutical Services, among others.
Pharma Blister Packaging utilizes various materials, including PVC, PVdC, and ALU-ALU, each offering unique properties to meet specific product requirements.
Pharma Blister Packaging plays a vital role in patient safety by providing tamper-evident seals, child-resistant designs, and moisture barriers, ensuring the integrity and efficacy of pharmaceutical products.
The Pharma Blisters Packaging Market faces challenges such as stringent regulatory compliance, environmental concerns related to plastic waste, and the need for continuous innovation to meet evolving pharmaceutical industry demands.
The Pharma Blisters Packaging Market presents growth opportunities in emerging markets, the development of sustainable and eco-friendly packaging solutions, and the integration of advanced technologies such as smart packaging.
Technology is revolutionizing Pharma Blisters Packaging through the advent of smart packaging, which enables real-time monitoring, patient adherence tracking, and enhanced product security.
